Author

David AMANTINI

PRECLINICAL MECHANISTIC INVESTIGATION OF THE FIRST-IN-CLASS SIK2/SIK3 INHIBITOR GLPG3970 IN AN EXPERIMENTAL MODEL OF IBD
PRECLINICAL MECHANISTIC INVESTIGATION OF THE FIRST-IN-CLASS SIK2/SIK3 INHIBITOR GLPG3970 IN AN EXPERIMENTAL MODEL OF IBD

David AMANTINI  et al.

PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION OF THE FIRST-IN-CLASS SELECTIVE SIK2/SIK3 INHIBITOR GLPG3970 IN EXPERIMENTAL MODELS OF IBD
PRECLINICAL IN VITRO AND IN VIVO INVESTIGATION OF THE FIRST-IN-CLASS SELECTIVE SIK2/SIK3 INHIBITOR GLPG3970 IN EXPERIMENTAL MODELS OF IBD

David AMANTINI  et al.

Item 1 - 2 / 2
1